دورية أكاديمية

Additional file 1 of Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

التفاصيل البيبلوغرافية
العنوان: Additional file 1 of Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
المؤلفون: Chaoyuan Kuang (11917136), Yongseok Park (11917139), Ryan C. Augustin (11917142), Yan Lin (285018), Douglas J. Hartman (5095124), Lindsey Seigh (11917145), Reetesh K. Pai (11917148), Weijing Sun (8929409), Nathan Bahary (4405), James Ohr (11917151), John C. Rhee (11917154), Stanley M. Marks (11917157), H. Scott Beasley (11917160), Yongli Shuai (518858), James G. Herman (7479164), Hassane M. Zarour (9859083), Edward Chu (62482), James J. Lee (7725938), Anuradha Krishnamurthy (11917163)
سنة النشر: 2022
المجموعة: Smithsonian Institution: Digital Repository
مصطلحات موضوعية: Medicine, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Colorectal cancer, Mismatch repair proficient, Immunotherapy, DNA methyltransferase inhibitor, Epigenetic therapy, Azacitidine, Pembrolizumab, PD-1, PD-L1
الوصف: Additional file 1. Clinical trial protocol.
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Pembrolizumab_plus_azacitidine_in_patients_with_chemotherapy_refractory_metastatic_colorectal_cancer_a_single-arm_phase_2_trial_and_correlative_biomarker_analysis/17982794Test
DOI: 10.6084/m9.figshare.17982794.v1
الإتاحة: https://doi.org/10.6084/m9.figshare.17982794.v1Test
حقوق: CC BY + CC0
رقم الانضمام: edsbas.721079F
قاعدة البيانات: BASE